RE: New prepri how #interferon acts as a bonafide adaptor of #stemcell output to demand in the young and9 Feb 2022 08:26
Great work, the evidence is becoming overwhelming. And this from the 11 Nov 2021 RNS from Buzz:
'Day 35 data will be reported in the first instance' !!!!
and Tom chips in with : Professor of Respiratory Medicine, and SPRINTER Trial Chief Investigator, said: "Over the past year, based on a growing body of clinical data, we have become even more confident that inhaled interferon beta may have an important role in helping hospitalised patients recover from COVID-19. Today's milestone brings us one step closer to evaluating the potential of SNG001 as an innovative, new therapy for hospitalised COVID-19 patients, something that is urgently needed."
IFN-beta is a naturally-occurring protein which orchestrates the body's antiviral responses. It is a well-tolerated drug and there is growing evidence that deficiency in IFN-beta production in the lungs could put vulnerable patient groups at risk of developing severe lower respiratory tract disease during respiratory viral infections.